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Evaluation of quality of life and photoplethysmography in 
patients with chronic venous insufficiency treated  
with foam sclerotherapy
Avaliação da qualidade de vida e fotopletismografia em pacientes com insuficiência 
venosa crônica tratados através de escleroterapia com espuma
Felipe Coelho Neto1,2*, Gilson Roberto Araújo2, Iruena Moraes Kessler1
Abstract
Background: Ultrasound-guided foam sclerotherapy plays a major role in treatment of chronic venous insufficiency, 
providing clinical and hemodynamic improvement to patients undergoing treatment. Objectives: To examine the 
relationships between venous refilling time and impact of venous disease on quality of life and between changes in 
venous refilling time and improvement of symptoms after ultrasound-guided foam sclerotherapy for chronic venous 
insufficiency. Methods: Thirty-two patients classified as C4, C5 or C6 answered a questionnaire on quality of life 
and symptoms and their venous filling time was measured using photoplethysmography before and 45 days after 
treatment of chronic venous insufficiency with ultrasound-guided foam sclerotherapy. Results: Statistically significant 
improvements were observed in quality of life scores and in venous filling time and in the following symptoms: aching, 
heavy legs, restless legs, swelling, burning sensations, and throbbing (p<0.0001). A similar improvement was also seen 
in the work and social domains of quality of life (p<0.0001). Conclusions: As confirmed by questionnaire scores and 
venous refilling times, ultrasound-guided foam sclerotherapy demonstrated efficacy and resulted in high satisfaction 
levels and low rates of major complications. 
Keywords: quality of life; chronic venous insufficiency; photoplethysmography; sclerotherapy; sclerosing solutions; 
color Doppler ultrasonography; varicose veins.
Resumo
Contexto: A escleroterapia com espuma guiada por ultrassom (EGUS) ocupa lugar de destaque no tratamento da 
insuficiência venosa crônica (IVC), proporcionando melhora clínica e hemodinâmica aos pacientes submetidos ao 
tratamento. Objetivos: Verificar a correlação entre dados obtidos por questionário de qualidade de vida e de sintomas 
com dados obtidos por fotopletismografia (FPG), antes e depois do tratamento por escleroterapia com espuma guiada 
por ultrassom (EGUS) da insuficiência venosa crônica (IVC). Métodos: Um grupo de 32 pacientes, classificados como 
C4, C5 e C6, foi submetido à aplicação de questionário de qualidade de vida e sintomas, sendo aferido o tempo de 
enchimento venoso (TEV) por FPG antes e 45 dias depois do tratamento da IVC através de EGUS. O teste do sinal 
foi utilizado para análise estatística da melhora dos escores dos questionários e do TEV. O teste de McNemar foi 
utilizado para avaliação da melhora nos sintomas e do impacto do tratamento nas atividades laborais e sociais dos 
pacientes. Resultados: Houve melhora nos escores dos questionários de qualidade de vida e no TEV, com significância 
estatística (p<0,0001). Houve melhora estatisticamente significativa nos sintomas: dor, cansaço, edema, queimação, 
pernas inquietas e latejamento (p<0,0001). Incremento na qualidade laboral e social após o tratamento apresentou 
melhora estatisticamente significativa (p<0,0001). Não ocorreram complicações maiores ou efeitos adversos nesta 
série. Conclusões: A EGUS mostrou-se eficaz, com alto índice de satisfação e baixas taxas de complicacões maiores, 
ratificada pelos escores dos questionários e pelos TEVs aferidos pela FPG. 
Palavras-chave: qualidade de vida; insuficiência venosa crônica; fotopletismografia; escleroterapia; soluções esclerosantes; 
ultrassonografia Doppler em cores; varizes.
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INTRODUCTION
Chronic venous insufficiency (CVI) is a common 
disease in clinical practice. Its complications, especially 
venous stasis ulcers, cause significant morbidity, loss 
of functional mobility and reduced quality of life.1
The ideal treatment for primary varicose veins of 
lower limbs should be minimally invasive; repeatable 
whenever needed; free from significant complications; 
effective at eliminating reflux points; and of low cost; 
and should result in esthetic improvement while 
requiring little absence from work.2 Ultrasound-guided 
foam sclerotherapy (UGFS) is one option for the 
treatment of CVI that can meet these requirements.3
There are several studies of UGFS treatment for 
CVI reporting good clinical results and high rates 
of venous trunk occlusion assessed by vascular 
echography.4,5
However, few publications have confirmed the 
clinical results obtained with UGFS using objective 
parameters, such as the hemodynamic variations 
provoked by the treatment.
Quality of life questionnaires can be used as the 
parameters of subjective assessments of treatment 
efficacy. The Venous Insufficiency Epidemiological 
and Economic Study’s Quality of Life/Symptom 
questionnaire (VEINES-QOL/Sym) consists of a 
self-report questionnaire addressing symptoms, 
their impact on daily activities and the psychological 
aspects of the disease.6 Higher scores indicate better 
outcomes.6,7
The hemodynamic variations provoked by treatment 
of CVI with UGFS can be determined by using 
photoplethysmography (PPG) to specifically measure 
venous refilling time (VRT). Venous refilling times 
obtained by PPG exhibit good correlations with direct 
measures of venous pressure.8-10 In turn, PPG is a 
rapid, non-invasive method suitable for outpatient 
settings that can provide quantitative and objective 
data to supplement the anatomical assessment and 
study of CVI11 both before and after therapeutic 
interventions.12
In view of the above, this study aimed to evaluate 
the efficacy of treatment for CVI using UGFS, by 
correlating VRT values as measured by PPG with 
data obtained by administration of a questionnaire 
on quality of life and symptoms before and 45 days 
after treatment.
METHODS
An open prospective study was conducted to 
evaluate VRT, as assessed by digital PPG, and the 
scores obtained by administration of a questionnaire 
on quality of life and symptoms before and 45 days 
after treatment of varicose veins with UGFS. The study 
was carried out at the Vascular Surgery outpatients 
clinic at a public hospital in the city of Brasília, 
Federal District of Brazil, from December 2012 to 
August 2013.
We selected patients over 18 years of age who 
presented with CVI of the lower limbs and were 
classified as C4, C5 or C6, according to the Clinical, 
Etiological, Anatomical, Pathophysiological (CEAP) 
classification.13 In order to obtain a homogenous 
sample, patients with deep venous thrombosis (DVT) 
identified by ultrasound examination were excluded 
from the study, as were patients with varicose veins 
but no involvement of the great or small saphenous 
vein. Cases of thrombophilia, active neoplasms or 
neoplasms in follow-up, reported lung disease, and 
peripheral artery insufficiency (ankle-arm index < 0.9) 
were also excluded.
All patients signed a written consent form after 
being informed about the details of the study.
Duplex ultrasound examination
All examinations were performed in a standardized 
manner by the same physician (FCN) using a MyLab 
40 ultrasound machine (Esaote™. Genoa, Italy) with 
a multifrequency 10-12 MHz transducer. Patients 
were placed in the standing position with their 
weight on the contralateral limb and the leg to be 
examined slightly rotated with the heel on the floor 
to relax the calf muscle while maintaining stability. 
The deep venous system was evaluated for DVT, 
and the superficial venous system was evaluated 
focusing on saphenofemoral and saphenopopliteal 
junctions, great and short saphenous veins, and on the 
presence of incompetent perforating veins. Reflux was 
induced with manual calf squeeze and was defined as 
reverse flow with duration longer than 0.5 seconds 
for saphenous vein and 0.35 seconds for perforating 
veins.14 Only perforating veins with diameters greater 
than 3.5 mm at the fascial level were considered for 
analysis, and reflux was recorded as described by 
Sandri et al.15
Photoplethysmography
A Hadeco PPG machine (Hayashi Denki CO. LTD, 
Kawasaki, Japan) was used to measure post-exercise 
VRT in the sitting position with the limb suspended, 
as described by Sam et al.16 Measurements were all 
taken at the same time of the day and in the same 
room. The PPG probe was attached to the skin using a 
sticky pad placed 13-39 cm above the medial malleolus 
and 1-2 cm posterior to the subcutaneous border of 
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the tibia, in order to avoid areas with trophic changes 
resulting from CVI. With the patient as motionless 
as possible, the machine calibrated the signal, and 
once a stable baseline was achieved, the exercise was 
initiated. Patients completed 10 dorsal and plantar 
flexions over a 15-second period and were then asked 
to remain at rest as motionless as possible.
The ejection of blood from the skin and the 
subsequent refilling curve were established and the 
machine calculated the venous filling curve. Three 
measurements were taken at intervals of 2-5 minutes, 
and the mean of all three measurements was used for 
analysis. Normal VRT was defined as ≥ 20 seconds. 
Measurements of VRT were performed on the day of 
the first sclerotherapy session and repeated in each 
treated limb 45 days after the end of the treatment, 
with the probe placed at the same height as that used 
in the pretreatment examination.
Quality of life and symptom questionnaire
The Brazilian Portuguese version of the VEINES-
QOL/Sym questionnaire17 was administered in the 
form of an interview, which was performed by a single 
researcher (FCN). The questionnaire was administered 
on the day of the first session and 45 days after the 
end of treatment.
Sclerotherapy technique
We have described the sclerotherapy technique 
elsewhere,18 focusing on the reflux pattern presented for 
each patient. When total occlusion of the target veins 
was not achieved in a single session, supplementary 
sessions were conducted, during which one or more 
punctures were performed, as required in each case, 
with 7-day intervals between sessions. The foam was 
produced by mixing 3% polidocanol with ambient 
air at a ratio of 1:4, and the maximum total volume 
of foam injected in a single session was 10 mL. 
Compression stockings (15-30 mmHg) were prescribed 
to be worn day and night for 7 days, only removing 
them for the purposes of personal hygiene. From the 
7th day onwards, patients were recommended to wear 
stockings during the day only.
Statistical analysis
Non-parametric methods were applied using 
Microsoft Office Excel 2007 (Microsoft Corporation, 
Redmond, USA), SAS version 9.3 (SAS Institute 
Inc. Cary, USA), and R i386 3.0.1 (R Foundation for 
Statistical Computing, Vienna, Austria). The sign test 
was used to determine improvement in VRT and in 
VEINES-QOL/Sym scores. The McNemar test was 
performed to analyze improvement in symptoms. 
The cutoff for statistical significance was set at less 
than or equal to 5%.
Research ethics
The research project was submitted to and 
approved by the Research Ethics Committee (CAAE: 
06791512.1.0000.5553). Additionally, all patients 
signed a written consent form after being informed 
about the details of the study.
RESULTS
Thirty-two patients were recruited. Females accounted 
for 82% (26/32) of the patients and mean age was 
52 years (range 36-76 years). The left lower limb 
was the most frequently affected limb, representing 
57% (18/32) of the sample. None of the patients had 
undergone previous invasive treatment at the point of 
enrollment on the study. Other epidemiological data 
are shown in Table 1.
Family history of DVT was present in four patients 
(13%), and three (10%) had a history of fracture 
and/or limb immobilization. Healed or active venous 
ulcers were present in 68% of the sample. The most 
frequent comorbidities were high blood pressure in 
eight individuals (25%) and diabetes in four (13%).
The patients’ CEAP classifications broke down as 
follows: 10 (32%) were classified as C4, seven (22%) 
as C5, and 15 (47%) as C6. All patients had a primary 
etiological classification. Anatomical classification was 
62.5% for superficial veins and 37.5% for perforating 
veins. Reflux was the pathophysiology in all patients.
The mean number of punctures required per patient 
was 3.96 (3-7), the mean number of sessions was 
1.4 (1-3) and the mean volume of foam per session 
was 8.5 mL (10-23 mL).
There were five response options for questionnaire 
items referring to symptoms: “every day”, “several 
times a week”, “about once a week”, “less than once a 
week”, and “never”. There was significant improvement 
in all items, as shown in Figure 1. For the purposes 
of statistical analysis, the responses “every day”, 
“several times a week”, and “about once a week” 
Table 1. Epidemiological data.
Variables Total Percentage (%)
Previous DVT 1 4
Family history of DVT 4 13
Previous ulcer 28 68
High blood pressure 8 25
Diabetes mellitus 4 13
Fracture/immobilization 3 10
DVT: deep vein thrombosis.
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were collapsed into a single category - group 1 - and 
the responses “less than once a week” and “never” 
were collapsed to form group 2. Group 1 responses 
were defined as indicating absence of improvement 
while group 2 responses represented improvements 
in the symptoms evaluated. All items exhibited 
statistical significance to p<0.001, except for the items 
“itching” and “tingling sensation”. The p values for 
improvements in symptoms are shown in Table 2.
Patients were also asked about the time of the day 
during which their leg problem was most severe. After 
treatment, 25% of the study population did not report 
any complaint during the entire day.
The next item on the questionnaire was: “Compared 
to one year ago, how would you rate your leg 
problem in general now?”. Before treatment, 56% 
of patients reported that the problem was somewhat 
worse or much worse than one year previously. After 
treatment, 100% of the patients reported that the 
problem was somewhat better or much better than 
one year previously.
Treatment resulted in improvement in patients’ work 
activities and the percentage of patients who answered 
that the problem did not limit their work activities at 
all increased from 34% to 75%. Additionally, none 
of the patients reported that the problem limited their 
activities a lot after treatment. When asked about 
limitations to daily household activities caused by 
their leg problem, 97% of patients answered that the 
problem did not cause any limitation to household 
activities. All items related to the impact of the disease 
on work or personal activities exhibited statistical 
significance to p<0.0001, as shown in Table 3.
There were improvements in activities performed 
both in standing and sitting positions, with the number 
of patients who answered that the problem did not 
limit these types of activity increasing from 34 to 94% 
and from 47 to 97% respectively.
These improvements attained statistical significance 
for both items (p<0.01), as shown in Table 4.
Patients who did not report any limitation to social 
activities with friends and family accounted for 94% 
of the sample after treatment (p<0.01), in contrast 
with 37% of the sample before treatment. Before 
treatment, patients who answered that the problem 
interfered “extremely”, “quite a bit” or “moderately” 
had accounted for 50% of the sample.
There was a specific item to assess the symptom 
“pain”. Before treatment, 25% of patients had 
reported “very severe” or “severe” pain, whereas 
after treatment this figure was 12%. Conversely, 19% 
of patients had reported “very mild” or “no” pain 
before treatment and this figure had risen to 56% 
after the procedure. Although the sample exhibited 
improvement in complaints of pain, these were not 
statistically significant (p>0.05).
Figure 1. Improvement in symptoms.











Table 3. Improvement in work activities.
Work activities p-value
Reduction in the amount of time spent at work <0.0001
Reduction in the amount of work accomplished <0.0001
Limitation in work time <0.0001
Difficulty in performing work <0.0001
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The psychological impact of leg problems on 
patients’ daily lives was also analyzed. The percentage 
of patients who answered that they felt concerned 
about their appearance “all of the time” or “most of 
the time” decreased from 62% before treatment to 
6% after treatment, while the percentage of those who 
reported feeling concerned about their appearance “a 
little of the time” or “none of the time” increased from 
25% to 78% of the sample. After treatment, 87% of the 
patients reported feeling irritated “none of the time”. 
Half of the patients did not feel they were a burden 
to their family and friends before treatment and this 
figure had increased to 100% after treatment. Initially, 
60% of the patients were worried about bumping 
into things “all of the time”. After intervention, this 
value had fallen to 6%. Additionally, before UGFS 
72% of patients had answered that the appearance of 
their legs influenced their choice of clothing “all of 
the time” and this percentage had decreased to 22% 
after the procedure.
The mean result for VRT before treatment was 
6.7 seconds (2.0-15.3 seconds) and after treatment 
mean VRT was 22.2 seconds (6.0-53.2 seconds), 
which is an increase of more than 230%.
Before treatment, the mean VEINES-QOL score 
was 44.8 (40.2-53.4), and the mean VEINES- Sym 
score was 45.03 (39.1-53.1). After treatment, the 
mean VEINES-QOL and VEINES- Sym scores were 
54.6 (48.2-57.3) and 54.1 (47.1-57.6) respectively.
Figure 2 compares VRT values before and after 
treatment, and Figures 3 and 4 show before and after 
results for VEINES-QOL and VEINES-Sym scores 
respectively. Statistically significant improvements 
(p<0.0001) were observed in VRT values and in both 
questionnaire scores after treatment.
There were no major complications such as DVT 
or pulmonary embolism during follow-up. Phlebitis 
(19%), local pain (90%), pigmentation (97%), and 
local induration (97%) were the most frequent minor 
complications.
Seven (47%) of the patients classified as C6 exhibited 
healed ulcers at 45 days after treatment. There were 
no cases of ulcer recurrence in the C5 group.
DISCUSSION
Over the last decade, alternative treatments for 
CVI such as endovenous thermal ablation and UGFS 
have become popular. These are outpatient procedures 
performed with local tumescent anesthesia that do not 
require hospitalization or absence from daily activities 
and several studies have demonstrated that they are 
safe and effective for eliminating venous reflux.19-22 
Furthermore, the clinical impact of these treatments 
can be measured by quality of life questionnaires, 
whether specific14, 23 or generic.24
Ambulatory venous pressure is considered the 
best parameter for evaluation of hemodynamic 
Figure 2. VRT values before and after treatment with UGFS. VRT: 
venous refilling time; UGFS: ultrasound-guided foam sclerotherapy.
Figure 3. VEINES-QOL scores before and after treatment with 
UGFS. VEINES-QOL: Venous Insufficiency Epidemiological and 
Economic Study - Quality of Life; UGFS: ultrasound-guided 
foam sclerotherapy.
Table 4. Impact of the disease on personal activities.
Personal activities p-value
Daily work activities 0.002
Daily household activities <0.001
Social or leisure activities performed in the standing 
position
<0.001
Social or leisure activities performed in the sitting 
position
<0.001
Figure 4. VEINES-Sym scores before and after treatment with 
UGFS. VEINES-Sym: Venous Insufficiency Epidemiological and 
Economic Study - Symptoms; UGFS: ultrasound-guided foam 
sclerotherapy.
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improvement after treatment, but it is an invasive 
method with limited applications in routine practice.25 
Air plethysmography is an effective alternative for 
measuring CVI severity,26 but it is a long test that 
requires a large instrument.2 In turn, VRT as measured 
by PPG offers good reproducibility and good correlation 
with direct measures of venous pressure.9 Moreover, 
it is a rapid test performed with a portable device and 
can be widely used in clinical practice.
Our data consistently demonstrated that there was an 
improvement in symptoms after treatment and confirm 
findings reported by Bradbury et al.11 The portion of 
the questionnaire related to symptoms (VEINES-Sym) 
identified improvements in all nine items 45 days 
after treatment, with statistical significance for the 
following items: pain, heavy legs, swelling, burning 
sensation, restless legs, and throbbing (p<0.0001). 
The portion of the questionnaire related to quality 
of life (VEINES-QOL) confirmed these data, since 
it showed that 100% of patients reported being 
somewhat better (6%) or much better (94%) than 
one year before treatment. There were statistically 
significant improvements in the ability to perform 
both work and household activities, with 75% of 
patients reporting no limitation to work activities and 
97% of patients reporting no difficulty in performing 
their usual household activities or social activities 
with friends and/or family.
We would like to draw attention to the improvement 
in pain, evidenced by the increase from 25 to 56% in 
the percentage of patients with no pain or complaining 
of very mild pain. Although analysis of this data did 
not reveal statistical significance, this improvement 
confirms findings previously reported in the literature.27 
The analysis of patients’ psychological profiles also 
revealed improvements in all questionnaire items. 
The instrument is therefore an important tool for 
evaluating treatment outcomes, since patients have 
usually been dealing with CVI for a long time, often 
relying on palliative treatments that have failed to 
achieve definitive resolution of the disease.28
There were no thromboembolic events or adverse 
effects resulting from sclerotherapy in this series 
of patients. Conversely, local complications were 
observed, including pigmentation, induration, and pain 
in the varicosities treated. These complications did 
not cause severe clinical repercussions, as confirmed 
by the high rate of patient satisfaction observed in 
the responses to the VEINES-QOL. Our data reveal 
higher local complication rates after UGFS than 
reported in other publications.29,30 Notwithstanding, 
the majority of patients in those studies were classified 
as CEAP 2-3, which means less severe clinical CVI 
status. It is believed that the higher rate of complications 
found in this study is the result of actively searching 
for information and the fact that most of our cases 
presented thicker varicose veins (CEAP 5 and 6).
Mean VRT as measured by PPG increased 
from 6.7 before treatment to 22.2 after treatment 
(p<0.0001). This finding had a statistically significant 
direct relationship with the increase in VEINES-
QOL/Sym scores, which confirms that VRT may 
have applications as an objective marker of short term 
clinical improvement in patients who have had UGFS 
treatment. As demonstrated by Kulkarni et al.,12 VRT 
may be an effective marker of venous ulcer recurrence 
when it does not improve after treatment. There 
were no cases of deep venous reflux in the sample. 
Therefore, the lack of improvement in VRT exhibited 
by patients can be explained by calf pump failure or 
restriction of ankle mobility as a result of trophic skin 
changes. In our experience, the improvement in VRT 
was associated with a rate of ulcer healing of 47% in 
patients classified as C6, 45 days after treatment with 
UGFS. The sample size and the limited follow-up 
time are weaknesses of our study.
However, the VEINES QOL/Sym questionnaire 
has never been used before to assess the results of 
CVI treatment using UGFS. The VEINES-QOL/Sym 
was the only questionnaire available that had been 
translated and adapted for use with the Brazilian 
population at the start of this study. Although other more 
specific questionnaires for venous ulcers exist, such 
as the Charing Cross Venous Ulcer Questionnaire,31 
they were not available for use at the start of our 
research project.
This study is the first report of use of this 
questionnaire for this purpose and shows that the 
VEINES QOL/Sym questionnaire is a feasible tool 
that exhibited a direct relationship with the objective 
hemodynamic measure obtained by PPG, in addition 
to portraying the psychological impact of the treatment 
on quality of life in the short-term.
In turn, UGFS proved to be effective and resulted 
in high levels of satisfaction and low rates of major 
complications, confirmed by the VEINES QOL/Sym 
scores and by VRT as measured by PPG.
Further studies are needed to evaluate medium-term 
and long-term results in order to analyze whether the 
results we obtained will be maintained and whether 
patients will still be free of symptoms and will exhibit 
sustained hemodynamic improvement after longer 
follow-up.
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